John P. Leonard
Active 1979–2025
- 171
- Papers
- 30,706
- Citations
- 93
- h-index
- 165
- i10-index
Citations
Citation sources
Countries
Institutions
Fields
- Medicine57.6%
- Biochemistry, Genetics and Molecular Biology27.9%
- Immunology and Microbiology8.4%
- Neuroscience3.4%
- Engineering0.4%
- Computer Science0.4%
- Other1.9%
Topics
- Lymphoma Diagnosis and Treatment10.5%
- CAR-T cell therapy research4.9%
- Chronic Lymphocytic Leukemia Research4.8%
- Immune Cell Function and Interaction3%
- Viral-associated cancers and disorders2.3%
- CNS Lymphoma Diagnosis and Treatment2.2%
- Other72.3%
Coauthors
- Nancy L. Bartlett39
- Jonathan W. Friedberg34
- Brad S. Kahl32
- Peter Martin32
- Morton Coleman24
- Jia Ruan20
- Eric D. Hsi19
- Richard R. Furman19
- Sonali M. Smith19
- Bruce D. Cheson18
- Kristie A. Blum14
- Sarah C. Rutherford14
- Michael LeBlanc13
- Carla Casulo12
- Hongli Li12
- Amy Chadburn11
- Ann S. LaCasce11
- Heiko Schöder11
- Lale Kostakoglu11
- Nina D. Wagner‐Johnston11
- Selina Chen‐Kiang11
- Andrew M. Evens10
- Giorgio Inghirami10
- Julie M. Vose10
All papers
- CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
Authors: Julian D. Gillmore, Ed Gane, Jörg Täubel, Justin Kao, Marianna Fontana, Michael L. Maitland, Jessica Seitzer, Daniel O’Connell, Kathryn Walsh, Kristy Wood, Jonathan D. Phillips, Yuanxin Xu, Adam Amaral, Adam P. Boyd, Jeffrey Cehelsky, Mark D. McKee, Andrew Schiermeier, Olivier Harari, Andrew Murphy, Christos A. Kyratsous, Brian Zambrowicz, Randy Soltys, David E. Gutstein, John P. Leonard, Laura Sepp‐Lorenzino, David Lebwohl - New England Journal of Medicine 2021 cited by 1,633
- The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
Authors: Elı́as Campo, Elaine S. Jaffe, James R. Cook, Leticia Quintanilla‐Martínez, Steven H. Swerdlow, Kenneth C. Anderson, Pierre Brousset, Lorenzo Cerroni, Laurence de Leval, Stefan Dirnhofer, Ahmet Doǧan, Andrew L. Feldman, Falko Fend, Jonathan W. Friedberg, Philippe Gaulard, Paolo Ghia, Steven M. Horwitz, Rebecca L. King, Gilles Salles, Jesús F. San Miguel, John F. Seymour, Steven P. Treon, Julie M. Vose, Emanuele Zucca, Ranjana H. Advani, Stephen M. Ansell, Wing-Yan Au, Carlos Barrionuevo, Leif Bergsagel, Wing C. Chan, Jeffrey I. Cohen, Francesco d’Amore, Andrew Davies, Brunangelo Falini, Irene M. Ghobrial, John R. Goodlad, John G. Gribben, Eric D. Hsi, Brad S. Kahl, Won-Seog Kim, Shaji Kumar, Ann S. LaCasce, Camille Laurent, Georg Lenz, John P. Leonard, Michael P. Link, Armando López‐Guillermo, María‐Victoria Mateos, Elizabeth Macintyre, Ari Melnick, Franck Morschhauser, Shigeo Nakamura, Marina Narbaitz, Astrid Pavlovsky, Stefano Pileri, Miguel Á. Piris, Barbara Pro, S. Vincent Rajkumar, Steven T. Rosen, Birgitta Sander, Laurie H. Sehn, Margaret A. Shipp, Sonali M. Smith, Louis M. Staudt, Catherine Thieblemont, Thomas Tousseyn, Wyndham H. Wilson, Tadashi Yoshino, Pier Luigi Zinzani, Martin Dreyling, David W. Scott, Jane N. Winter, Andrew D. Zelenetz - Blood 2022 cited by 1,506
- Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
Authors: Roland Schmitz, George W. Wright, Da Wei Huang, Calvin A. Johnson, James D. Phelan, James Q. Wang, Sandrine Roulland, Monica Kasbekar, Ryan M. Young, Arthur L. Shaffer, Daniel J. Hodson, Wenming Xiao, Xin Yu, Yandan Yang, Hong Zhao, Weihong Xu, Xuelu Liu, Bin Zhou, Wei Du, Wing C. Chan, Elaine S. Jaffe, Randy D. Gascoyne, Joseph M. Connors, Elı́as Campo, Armando López‐Guillermo, Andreas Rosenwald, German Ott, Jan Delabie, Lisa M. Rimsza, Kevin Tay Kuang Wei, Andrew D. Zelenetz, John P. Leonard, Nancy L. Bartlett, Bao Tran, Jyoti Shetty, Yongmei Zhao, Dan Soppet, Stefania Pittaluga, Wyndham H. Wilson, Louis M. Staudt - New England Journal of Medicine 2018 cited by 2,261
- CRISPR-Cas9 In Vivo Gene Editing of KLKB1 for Hereditary Angioedema
Authors: Hilary Longhurst, Karen Lindsay, Remy S. Petersen, Lauré M. Fijen, Padmalal Gurugama, David Maag, James S. Butler, Mrinal Y. Shah, A. Golden, Yuanxin Xu, Carri Boiselle, Joseph D Vogel, Ahmed M. Abdelhady, Michael L. Maitland, Mark D. McKee, Jessica Seitzer, Bo Han, Samantha Soukamneuth, John P. Leonard, Laura Sepp‐Lorenzino, Eliana D Clark, David Lebwohl, Danny M. Cohn - New England Journal of Medicine 2024 cited by 166
- Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity
Authors: Wyndham H. Wilson, Owen A. O’Connor, Myron S. Czuczman, Ann S. LaCasce, John F. Gerecitano, John P. Leonard, Anil Tulpule, Kieron Dunleavy, Hao Xiong, Yi‐Lin Chiu, Yue Cui, Todd Busman, Steven W. Elmore, Saul H. Rosenberg, Andrew Krivoshik, Sari H. Enschede, Rod Humerickhouse - The Lancet Oncology 2010 cited by 853
- Clinical and Biological Subtypes of B-cell Lymphoma Revealed by Microenvironmental Signatures
Authors: Nikita Kotlov, Alexander Bagaev, María V. Revuelta, Jude M. Phillip, Maria Teresa Cacciapuoti, Zoya Antysheva, Viktor Svekolkin, Ekaterina Tikhonova, Natalia Miheecheva, Natalia Kuzkina, Grigorii Nos, Fabrizio Tabbò, Felix Frenkel, Paola Ghione, Maria Tsiper, Nava Almog, Nathan Fowler, Ari Melnick, John P. Leonard, Giorgio Inghirami, Leandro Cerchietti - Cancer Discovery 2021 cited by 251
- AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma
Authors: John P. Leonard, Marek Trněný, Koji Izutsu, Nathan Fowler, Xiaonan Hong, Jun Zhu, Huilai Zhang, Fritz Offner, Adriana Scheliga, Grzegorz S. Nowakowski, Antonio Pinto, Francesca Re, Laura Maria Fogliatto, Phillip Scheinberg, Ian W. Flinn, Cláudia Moreira, José Cabeçadas, David Liu, Stacey Kalambakas, Pierre Fustier, Chengqing Wu, John G. Gribben, for the AUGMENT Trial Investigators - Journal of Clinical Oncology 2019 cited by 421
- Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303
Authors: Nancy L. Bartlett, Wyndham H. Wilson, Sin‐Ho Jung, Eric D. Hsi, Matthew J. Maurer, Levi Pederson, Mei‐Yin C. Polley, Brandelyn N. Pitcher, Bruce D. Cheson, Brad S. Kahl, Jonathan W. Friedberg, Louis M. Staudt, Nina D. Wagner‐Johnston, Kristie A. Blum, Jeremy S. Abramson, Nishitha Reddy, Jane N. Winter, Julie Chang, Ajay K. Gopal, Amy Chadburn, Susan Mathew, Richard I. Fisher, Kristy L. Richards, Heiko Schöder, Andrew D. Zelenetz, John P. Leonard - Journal of Clinical Oncology 2019 cited by 423
- Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production.
Authors: John P. Leonard, Matthew L. Sherman, Gerald L. Fisher, Lynn J. Buchanan, G R Larsen, Michael B. Atkins, Jeffrey A. Sosman, Janice P. Dutcher, Nicholas J. Vogelzang, John L. Ryan - 1997 cited by 814
- Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas
Authors: Anas Younes, Nancy L. Bartlett, John P. Leonard, Dana A. Kennedy, Carmel M. Lynch, Eric L. Sievers, Andres Forero‐Torres - New England Journal of Medicine 2010 cited by 1,353
- SWOG S1826, a randomized study of nivolumab(N)-AVD versus brentuximab vedotin(BV)-AVD in advanced stage (AS) classic Hodgkin lymphoma (HL).
Authors: Alex F. Herrera, Michael LeBlanc, Sharon M. Castellino, Hongli Li, Sarah C. Rutherford, Andrew M. Evens, Kelly Davison, Angela Punnett, David Hodgson, Susan K. Parsons, Sairah Ahmed, Carla Casulo, Nancy L. Bartlett, Joo Y. Song, Richard F. Little, Brad S. Kahl, John P. Leonard, Kara M. Kelly, Sonali M. Smith, Jonathan W. Friedberg - Journal of Clinical Oncology 2023 cited by 117
- Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
Authors: Richard Piekarz, Robin Frye, Maria L. Turner, John J. Wright, Steven L. Allen, Mark Kirschbaum, Jasmine Zain, H. Miles Prince, John P. Leonard, Larisa J. Geskin, Craig B. Reeder, David Joske, William D. Figg, Erin R. Gardner, Seth M. Steinberg, Elaine S. Jaffe, Maryalice Stetler‐Stevenson, Stephen Lade, Antonio Tito Fojo, Susan E. Bates - Journal of Clinical Oncology 2009 cited by 737
- Phase I Study of the Novel Enhancer of Zeste Homolog 2 (EZH2) Inhibitor GSK2816126 in Patients with Advanced Hematologic and Solid Tumors
Authors: Timothy A. Yap, Jane N. Winter, Lisa Giulino‐Roth, Jemma Longley, Juanita Lopez, Jean‐Marie Michot, John P. Leonard, Vincent Ribrag, Michael T. McCabe, Caretha L. Creasy, Melissa Stern, Teodora Pene Dumitrescu, Xiaowei Wang, Steve Frey, Jennifer Carver, Thierry Horner, Choon Oh, Ahmed Khaled, Arindam Dhar, Peter Johnson - Clinical Cancer Research 2019 cited by 164
- Safety and efficacy of navitoclax, a BCL-2 and BCL-X L inhibitor, in patients with relapsed or refractory lymphoid malignancies: results from a phase 2a study
Authors: Sven de Vos, John P. Leonard, Jonathan W. Friedberg, Jasmine Zain, Kieron Dunleavy, Rod Humerickhouse, John Hayslip, John C. Pesko, Wyndham H. Wilson - Leukemia & lymphoma/Leukemia and lymphoma 2020 cited by 93
- Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma
Authors: Alex F. Herrera, Michael LeBlanc, Sharon M. Castellino, Hongli Li, Sarah C. Rutherford, Andrew M. Evens, Kelly Davison, Angela Punnett, Susan K. Parsons, Sairah Ahmed, Carla Casulo, Nancy L. Bartlett, Joseph M. Tuscano, Matthew Mei, Brian Hess, Ryan Jacobs, Hayder Saeed, Pallawi Torka, Boyu Hu, Craig H. Moskowitz, Supreet Kaur, Gaurav Goyal, Christopher J. Forlenza, Andrew Doan, Adam J. Lamble, Pankaj Kumar, Saeeda Chowdhury, Brett T. Brinker, Namita Sharma, Avina K. Singh, Kristie A. Blum, Anamarija M. Perry, Alexandra E. Kovach, David Hodgson, Louis S. Constine, Lale Kostakoglu Shields, Anca Prica, Hildy Dillon, Richard F. Little, Margaret A. Shipp, Michael Crump, Brad S. Kahl, John P. Leonard, Sonali M. Smith, Joo Y. Song, Kara M. Kelly, Jonathan W. Friedberg - New England Journal of Medicine 2024 cited by 200
- Biomarkers and cardiovascular outcomes in chimeric antigen receptor T-cell therapy recipients
Authors: Syed Mahmood, Peter A. Riedell, Stephanie Feldman, Gina George, Stephen Sansoterra, Thomas Althaus, Mahin Rehman, Elena Mead, Jennifer E. Liu, Richard B. Devereux, Jonathan W. Weinsaft, Jiwon Kim, Lauren Balkan, Tarek Barbar, Katherine Lee Chuy, Bhisham Harchandani, Miguel‐Angel Perales, Mark B. Geyer, Jae H. Park, M Lia Palomba, Roni Shouval, Ana Alarcón Tomás, Gunjan L. Shah, Eric H. Yang, Daria Gaut, Michael Rothberg, Evelyn M. Horn, John P. Leonard, Koen van Besien, Matthew J. Frigault, Zhengming Chen, Bhoomi Mehrotra, Tomas G. Neilan, Richard M. Steingart - European Heart Journal 2023 cited by 48
- Postibrutinib outcomes in patients with mantle cell lymphoma
Authors: Peter Martin, Kami J. Maddocks, John P. Leonard, Jia Ruan, André Goy, Nina D. Wagner‐Johnston, Simon Rule, Ranjana H. Advani, David Iberri, Tycel Phillips, Stephen E. Spurgeon, Eliana Kozin, Katherine Noto, Zhengming Chen, Wojciech Jurczak, Rebecca Auer, Ewa Chmielowska, Stephan Stilgenbauer, Johannes Bloehdorn, Craig A. Portell, Michael E. Williams, Martin Dreyling, Paul M. Barr, Selina Chen‐Kiang, Maurizio DiLiberto, Richard R. Furman, Kristie A. Blum - Blood 2016 cited by 283
- Randomized Phase III Study of Alisertib or Investigator’s Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma
Authors: Owen A. O’Connor, Muhıt Özcan, Eric D. Jacobsen, Josep M. Roncero, Judith Trotman, Judit Demeter, Tamás Masszi, Juliana Pereira, Radhakrishnan Ramchandren, Anne Beaven, Dolores Caballero, Steven M. Horwitz, Anne Lennard, Mehmet Turgut, Nelson Hamerschlak, Francesco d’Amore, Francine M. Foss, Won-Seog Kim, John P. Leonard, Pier Luigi Zinzani, Carlos Chiattone, Eric D. Hsi, Lorenz Trümper, Hua Liu, Emily Sheldon‐Waniga, Claudio Dansky Ullmann, Karthik Venkatakrishnan, E. Jane Leonard, Andrei R. Shustov, on behalf of the Lumiere Study Investigators - Journal of Clinical Oncology 2019 cited by 150
- Cell-Cycle Reprogramming for PI3K Inhibition Overrides a Relapse-Specific C481S BTK Mutation Revealed by Longitudinal Functional Genomics in Mantle Cell Lymphoma
Authors: David Chiron, Maurizio Di Liberto, Peter Martin, Xiangao Huang, Jeff P. Sharman, Pedro Blecua, Susan Mathew, Priyanka Vijay, Ken Eng, Siraj M. Ali, Amy J. Johnson, Betty Chang, Scott Ely, Olivier Elemento, Christopher E. Mason, John P. Leonard, Selina Chen‐Kiang - Cancer Discovery 2014 cited by 272
- International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017)
Authors: Anas Younes, Patrick Hilden, Bertrand Coiffier, Anton Hagenbeek, Gilles Salles, Wyndham H. Wilson, John F. Seymour, Kara M. Kelly, John G. Gribben, M. Pfreunschuh, Franck Morschhauser, Heiko Schöder, Andrew D. Zelenetz, Jürgen Rademaker, Ranjana H. Advani, Nancy Valente, Catherine Fortpied, Thomas E. Witzig, Laurie H. Sehn, Andreas Engert, Richard I. Fisher, Pier Luigi Zinzani, Massimo Federico, Martin Hutchings, Catherine M. Bollard, Marek Trněný, Yusri Elsayed, Kensei Tobinai, Jeremy S. Abramson, Nathan Fowler, André Goy, Mitchell R. Smith, Stephen M. Ansell, John Kuruvilla, Martin Dreyling, Catherine Thiéblemont, Richard F. Little, Igor Aurer, Marinus H. J. van Oers, Kenichi Takeshita, Ajay K. Gopal, Simon Rule, Sven de Vos, Ioana Kloos, Mark Kaminski, Michel Meignan, Lawrence H. Schwartz, John P. Leonard, Stephen J. Schuster, Venkatraman Seshan - Annals of Oncology 2017 cited by 377
- Prognostic value of interim FDG-PET in diffuse large cell lymphoma: results from the CALGB 50303 Clinical Trial
Authors: Heiko Schöder, Mei‐Yin C. Polley, Michael V. Knopp, Nathan C. Hall, Lale Kostakoglu, Jun Zhang, Howard R. Higley, Gary J. Kelloff, Heshan Liu, Andrew D. Zelenetz, Bruce D. Cheson, Nina D. Wagner‐Johnston, Brad S. Kahl, Jonathan W. Friedberg, Eric D. Hsi, John P. Leonard, Lawrence H. Schwartz, Wyndham H. Wilson, Nancy L. Bartlett - Blood 2020 cited by 94
- Positron Emission Tomography–Directed Therapy for Patients With Limited-Stage Diffuse Large B-Cell Lymphoma: Results of Intergroup National Clinical Trials Network Study S1001
Authors: Daniel O. Persky, Hongli Li, Deborah M. Stephens, Steven I. Park, Nancy L. Bartlett, Lode J. Swinnen, Paul M. Barr, Jerome D. Winegarden, Louis S. Constine, Thomas J. FitzGerald, John P. Leonard, Brad S. Kahl, Michael LeBlanc, Joo Y. Song, Richard I. Fisher, Lisa M. Rimsza, Sonali M. Smith, Thomas P. Miller, Jonathan W. Friedberg - Journal of Clinical Oncology 2020 cited by 128
- Mechanism-Based Epigenetic Chemosensitization Therapy of Diffuse Large B-Cell Lymphoma
Authors: Thomas Clozel, ShaoNing Yang, Rebecca Elstrom, Wayne Tam, Peter Martin, Matthías Kormáksson, Samprit Banerjee, Aparna Vasanthakumar, Biljana Čuljković, David W. Scott, Sarah Wyman, Micheal Leser, Rita Shaknovich, Amy Chadburn, Fabrizio Tabbò, Lucy A. Godley, Randy D. Gascoyne, Katherine L. B. Borden, Giorgio Inghirami, John P. Leonard, Ari Melnick, Leandro Cerchietti - Cancer Discovery 2013 cited by 214
- A Human Stem Cell Model of Fabry Disease Implicates LIMP-2 Accumulation in Cardiomyocyte Pathology
Authors: Matthew J. Birket, Sophie Raibaud, Miriam Lettieri, Antony Adamson, Valérie Letang, Pauline Cervello, Nicolas Redon, Gwénaëlle Ret, Sandra Viale, Bing Wang, Bruno Biton, Jean‐Claude Guillemot, Vincent Mikol, John P. Leonard, Neil A. Hanley, Cécile Orsini, Jean‐Michel Itier - Stem Cell Reports 2019 cited by 78
